Page 53 - Amgen News Today

Amgen (NASDAQ:AMGN – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided earnings per share guidance of $19.00 to $20.20 for the period, compared to the consensus earnings per share estimate of $19.47. The company issued revenue guidance of $32.5 billion to $33.8 billion, compared to the consensus revenue estimate of […]

Amgen reported non-GAAP EPS for the first three months of 2024 down 1% to $3.96 on Thursday evening, with non-GAAP operating margin down 5.1 points to 43.2% on revenues up 22% to $7.4 billion.The...

Thursday saw major U.S. indices closing on a positive note, with the Dow Jones Industrial Average climbing 0.85% to reach 38,225.66

U.S. stock index futures gained on Friday, lifted by upbeat corporate updates from Apple and Amgen, while traders braced for a key jobs report for a clearer outlook on the labor market and the...

Here are the biggest calls on Wall Street on Friday.

U.S. job growth slowed more than expected in April and the increase in annual wages fell below 4% for the first time in nearly three years. The unemployment rate came in higher than estimated. That prompted traders to boost bets that the Fed will deliver its first interest rate cut this year in September.

Wall Street's main indexes were set to open higher on Friday after a softer-than-expected jobs report revived hopes of the Federal Reserve cutting interest rates this year, while gains in Apple and Amgen on upbeat corporate updates added support. The Labor Department report showed U.S. nonfarm payrolls increased by 175,000 jobs in April, compared with expectations for an increase of 243,000, according to economists polled by Reuters. The unemployment rate stood at 3.9% compared with expecta...

NVIDIA announced the integration of NVIDIA NIM, a collection of cloud-native AI microservices, with Amazon Web Services (AWS).

MariTide, formerly AMG 133, is an injectable form of drug targeting two gut hormones — gastric inhibitory polypeptide receptor, or GIP, and glucagon-like peptide 1, or GLP-1.

Zymeworks Inc. (NYSE:ZYME) Q1 2024 Earnings Call Transcript May 2, 2024 Zymeworks Inc. misses on earnings expectations. Reported EPS is $-0.41513 EPS, expectations were $-0.31. Zymeworks Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. […]